For Immediate Release:
September 15, 2017 — Phoenix, AZ
Statement: PEPID, LLC, the leading developer of point-of-care clinical decision support solutions, will be participating in the ASHP Midyear 2018 Clinical Meeting and Exhibition as an exhibitor at booth #513. PEPID’s theme for the show will be “Moving Forward in Pharmacy,” showcasing the largest drug database on the market, the PEPID Knowledgebase, the Pharmacists Pro with AHFS suite, and its’ latest, cutting-edge project PEPID PGx.
The ASHP Midyear 2018 Clinical Meeting will take place December 3rd through 6th in Anaheim, California. The American Society of Health Pharmacists (ASHP) has been hosting the ASHP Midyear Clinical Meeting for four decades, drawing 25,000 attendees studying, teaching, and working in the field of Pharmacy each year.
Before the Midyear Meeting:
PEPID encourages ASHP goers to take advantage of their extended trial for both individuals and/or entire departments, including unrestricted trial access to the PEPID database for institutions looking for integration solutions. Access the extended trial information here.
During the Midyear Meeting:
At booth #513, PEPID will be giving away Kindle Fires preloaded with 6 months of Pharmacist Pro with AHFS to people who participate in their raffle. PEPID will have appreciation gifts for long-term users of PEPID at their booth #513. ASHP attendees will also have an opportunity to save on PEPID’s suites and data integration services with special ASHP on-the-floor only rates for both individuals and institutions.
ASHP attendees will be able to view and play with PEPID’s latest product: PEPID PGx. PEPID’s PGx combines proprietary, ingredient-based drug interaction algorithms that incorporate pharmacogenomics with the largest drug database on the market including extensive clinical and drug references. PEPID’s PGx interaction checker shows interaction severity weighting to determine if further consideration is necessary, full interaction monographs to provide an immediate and actionable overview, and references for further research and evaluation.
Learn more about PEPID at the ASHP Midyear Clinical Meeting.
The clinical decision tool of choice for clinicians in 159 countries, PEPID’s comprehensive tools enable healthcare professionals to efficiently pinpoint diagnoses, treat diseases, detect harmful drug interactions and allergy sensitivities, accurately dose patients, and provide quality patient education – all from the palm of the clinician’s hand. For more information on PEPID clinical decision support, please visit our products page.